16 Types of Dementia: Definitions, Causes, and Statistics that can be life-changing

You are here:

Table of Contents

Dementia is an umbrella term, defined as a disorder of mental processes caused by brain disorder or traumatic brain injury. As mental processes decline, memory is impaired, personality may change, and thinking/concentration skills deteriorate.

Alzheimer’s is the most common type of dementia — also referred to as the most common cause of dementia — but there are several other types of dementia.

At what age does dementia usually start? Dementia is most common in adults over 65. However, early- or young-onset dementia (diagnosed at 30-60 years old) may account for 5% of this disorder cases. 

More than 1/3 of individuals over the age of 90 suffer from some form of dementia.

Does dementia run in the family? Almost all forms of this disorder are not genetic.

Below, we cover the 16 most common types of dementia:

  1. Alzheimer’s disease
  2. Creutzfeld-Jakob disease
  3. Lewy Body Dementia
  4. Frontotemporal dementia
  5. Huntington’s disease
  6. Vascular dementia
  7. Alcohol-related brain damage
  8. Young-onset dementia
  9. Chronic traumatic encephalopathy (CTE)
  10. Neuroborreliosis (Lyme disease-associated cognitive decline)
  11. HIV-associated neurocognitive disorders
  12. Mild cognitive impairment
  13. Mixed dementia
  14. Normal-pressure hydrocephalus
  15. Posterior cortical atrophy
  16. Wernicke-Korsakoff syndrome

Want to prevent Alzheimer’s using a plan that works… without breaking the bank? Get our guide to the Bredesen Protocol on a budget for $29.

Alzheimer’s Disease

In Alzheimer’s disease, a buildup of amyloid plaque and tau proteins on the brain leads to rapid cognitive decline.

Early signs of Alzheimer’s disease include:

  • Difficulty finding the right words
  • Forgetting recent events
  • Depression

Alzheimer’s can’t be cured or effectively treated in many cases. 

However, by addressing a combination of 36 lifestyle factors identified by Dr. Dale Bredesen, it is possible to reduce your risk of Alzheimer’s disease.

Alzheimer’s disease is the most common type of dementia, affecting one of every 10 older adults aged 65 and older.

Creutzfeldt-Jakob Disease

Creutzfeldt-Jakob disease is a rare, degenerative, and fatal brain disorder, first described by Hans Creutzfeldt in 1920. In the United States, about 350 adults are diagnosed every year. Creutzfeldt-Jakob disease often presents later in life — after the age of 55.

Also known as “subacute spongiform encephalopathy”, Creutzfeldt-Jakob disease is inherited in about 8-15% of cases. However, the overwhelming majority of cases occur spontaneously when misfolded proteins force other proteins to be misfolded. The initial cause of this process remains unknown.

More than two-thirds of people with this disease die within a year of diagnosis.

Early symptoms of Creutzfeldt-Jakob disease include:

  • Memory problems
  • Behavioral changes
  • Visual disturbances (hallucinations)
  • Coordination problems

Later symptoms of Creutzfeldt-Jakob disease include:

  • Dementia
  • Involuntary muscle movements
  • Blindness
  • Coma

What is the most aggressive form of dementia? The most aggressive form of this disorder may be Creutzfeldt-Jakob disease, a rare cause of dementia that often leads to death less than a year after the initial diagnosis of dementia.

Lewy Body Dementia

Lewy body dementia refers to abnormal microscopic deposits that damage brain cells over time, leading to cognitive decline.

Dr. Frederich Lewy discovered Lewy bodies in the early 1900s. Alpha-synuclein protein, the chief component of Lewy bodies, is widely found in the brain, although its intended function isn’t yet known.

No risk factors or causes of Lewy body dementia have been identified. Healthcare experts are fairly confident it isn’t genetic or based on family history.

Symptoms of Lewy body dementia include:

  • Confusion
  • Alertness that varies significantly from one day to the next
  • Impaired problem-solving skills
  • Slowness or balance issues
  • Visual hallucinations
  • Disorientation
  • Sleep disturbances
  • Nervous system dysfunction
  • Forgetfulness and memory problems

Dementia with Lewy bodies affects more than one million people in the United States alone — making it the third most common of the different types of dementia. It seems to affect slightly more women than men, according to the National Institute on Aging.

Frontotemporal Dementia (FTD)

Frontotemporal dementia (FTD) is caused by the loss of nerve cells in the brain’s frontal lobes (behind your forehead) or its temporal lobes (behind your ears).

Types of FTD and their primary symptoms include:

  1. Behavior variant — personality changes
  2. Primary progressive aphasia — language processing
  3. Corticobasal syndrome — arms and legs are uncoordinated and/or stiff
  4. Progressive supranuclear palsy — muscle stiffness, eye abnormalities
  5. Amyotrophic lateral sclerosis (ALS, Lou Gehrig’s disease) — muscle weakness, wasting

Rough estimates of FTD prevalence may be as high as 60,000 adults in the United States. Treatments include medication to improve quality of life, but not to reverse frontotemporal disorder.

Huntington’s Disease

Also known as “degenerative chorea”, Huntington’s disease is a genetic neurodegenerative disorder that leads to involuntary muscle movements (AKA chorea), personality changes, and this disorder over the course of 10-25 years.

Huntington’s is a rare genetic disease. Parents run about a 50% chance of passing Huntington’s to each child they bear.

About 300,000 Americans have Huntington’s, and it’s estimated that 200,000 more are at risk.

Symptoms usually begin appearing between the ages of 30 and 50. Patients with Huntington’s may live another 15-20 years after the onset of symptoms.

Vascular Dementia

Vascular dementia is caused by blocked or reduced blood flow to different regions of the brain. This deprives the brain of oxygen and nutrients, leading to symptoms of this disorder.

Also known as vascular cognitive impairment, this type of dementia can coexist with Alzheimer’s or Lewy body dementia. Memory loss may or may not be a major symptom, depending on the part of the brain that is affected.

Stroke sufferers who experience immediate cognitive impairment likely have vascular dementia because the stroke deprived their brains of oxygen and nutrients.

Vascular dementia is widely considered the second most common cause of this disorder, according to the Alzheimer’s Association. It accounts for 5-10% of dementia cases. However, experts believe that vascular dementia often goes underdiagnosed.

In order to prevent stroke and vascular dementia, keep a healthy cardiovascular system by exercising regularly, maintaining a healthy weight, quitting smoking, and limiting alcohol consumption.

Alcohol-Related Brain Damage

A healthy liver filters alcohol quickly. However, when someone consumes excessive alcohol, their liver cannot filter the alcohol fast enough. This can lead to immediate, lasting brain changes.

Excessive alcohol causes long-term negative effects on the neurotransmitters in your brain. Almost half of the alcoholics in America present with mild to severe cognitive impairment.

Alcoholism is also linked to several other health problems:

  • High blood pressure (AKA hypertension)
  • Heart disease
  • Anemia
  • Liver disease
  • Pancreatic problems
  • Immune dysfunction
  • Digestive disorders
  • Muscle weakness
  • Depression

Young-Onset Dementia

About 5-6% of those with Alzheimer’s develop symptoms before age 65. This is called early-onset or young-onset Alzheimer’s, the most common young-onset dementia.

Working-age individuals (under the age of 65) may also develop these young-onset dementias:

  • Vascular dementia
  • Frontotemporal dementia
  • Wernicke-Korsakoff Syndrome
  • Dementia with Lewy bodies
  • Creutzfeld-Jakob disease
  • Huntington’s disease
  • Parkinson’s disease dementia

Young-onset Wernicke-Korsakoff Syndrome may be brought on by alcohol abuse and a thiamine vitamin deficiency, so it can usually be prevented with abstinence from alcohol and eating a healthy, balanced diet. Regular exercise may help slow or stop other forms of cognitive decline.

Chronic Traumatic Encephalopathy (CTE)

Chronic traumatic encephalopathy (CTE) is a brain condition that results from repeated concussions and head trauma.

It has some similarities to Alzheimer’s, in that CTE happens because of abnormal tau plaque in the brain. However, CTE tau tangles form around small blood vessels and aren’t usually the beta amyloid plaques common to Alzheimer’s disease.

CTE causes dementia symptoms such as:

  • Memory loss
  • Personality changes
  • Angry outbursts and aggression
  • Depression and suicidal thoughts
  • Attention deficits

It’s impossible to diagnose CTE without an autopsy, but initial studies suggest it is very common in athletes in sports like American football.

Neuroborreliosis (Lyme Disease-Associated Cognitive Decline)

Lyme disease is a common tick-borne bacterial infection diagnosed in 300,000 Americans each year. While the early stages of Lyme can be reversed with proper antibiotic therapy, many cases go undiagnosed and can lead to a lifetime of chronic health problems.

Chronic Lyme disease can cause neuroborreliosis, a type of dementia. Neuroborreliosis symptoms vary and may include:

  • Cranial nerve palsy
  • Nerve pain
  • Brain inflammation (encephalitis)
  • Spinal cord inflammation (myelitis)
  • Headache
  • Back pain
  • Delirium (confusion, etc.)

Some cases of neuroborreliosis may be misdiagnosed as Alzheimer’s disease, like with musician and actor Kris Kristofferson. This condition may also present similar to a stroke, which is why cerebrospinal fluid (CSF) is necessary to make a proper diagnosis of neuroborreliosis.

HIV-Associated Neurocognitive Disorders (HAND)

HIV-associated neurocognitive disorders (HAND) are various neurological conditions connected to HIV and AIDS infections, usually appearing in the later stages.

HAND is one of the few conditions directly caused by HIV, whereas most complications of HIV come from opportunistic infections.

Also known as AIDS dementia complex, HAND typically presents the following symptoms:

  • Cognitive decline (which may take years to present)
  • Loss of fine motor control
  • Behavioral changes
  • Speech problems

With the growing popularity of highly active antiretroviral therapy (HAART), the incidence of HAND is declining in developed countries. HAART may prevent or delay the onset of HAND, or improve cognitive function in those who already have HAND.

In Western countries, HAND prevalence may be as high as 24% of HIV-infected individuals.

Mild Cognitive Impairment (MCI)

Mild cognitive impairment is the general term for early signs of dementia, or pre-dementia. This is not a normal part of aging.

MCI is a slight but noticeable cognitive decline, namely memory and thinking. It can be noticed by family members or caregivers, but shouldn’t directly impede the individual’s ability to go on with their daily life.

There are many potential causes of MCI, including some we don’t fully understand. Risk factors are basically the same as the risk factors for dementia in general: older age, family history of dementia, and cardiovascular disease.

About 15-20% of people age 65 or older have MCI. Because this is an early warning sign for Alzheimer’s or other dementias, seek medical advice right away if you or a loved one exhibits MCI.

Mixed Dementia

At least 10% of those suffering from dementia have more than one type of dementia. This is called “mixed dementia”.

The most common form of mixed dementia is the amyloid plaque buildup of Alzheimer’s coexisting with the blood vessel issues connected to vascular dementia.

Normal-Pressure Hydrocephalus

Normal-pressure hydrocephalus refers to an abnormal buildup of cerebrospinal fluid in the ventricle areas of the brain.

It may be caused by:

  • Tumors
  • Traumatic brain injury
  • Infection
  • Complications due to surgery

Symptoms of normal-pressure hydrocephalus include dementia, problems walking, slowness, and loss of bladder control.

Normal-pressure hydrocephalus may be treated by surgically placing a shunt in the brain to drain the excess cerebrospinal fluid.

Posterior Cortical Atrophy

Posterior cortical atrophy (PCA) describes the progressive degeneration of the outer layer of the brain. It affects your ability to process visual information.

PCA may be a distinct disorder or a variant of Alzheimer’s. It usually begins between the ages of 50 and 65, whereas Alzheimer’s often develops after the age of 65.

Many PCA patients show amyloid plaque and tangles like in Alzheimer’s, but in a separate part of the brain than Alzheimer’s.

Some researchers estimate 5-15% of Alzheimer’s patients suffer from PCA as well, but because the standard diagnostic criteria have not been established, it’s difficult to say.

Wernicke-Korsakoff Syndrome

Also called Gayet-Wernicke syndrome, Wernicke-Korsakoff syndrome is a type of dementia characterized by the following symptoms:

  • Accelerated memory loss
  • Confusion
  • Loss of bodily control (ataxia)
  • Eye abnormalities

Wernicke and Korsakoff syndromes are related conditions that often develop due to vitamin B1 (thiamine) deficiency. Most cases occur in alcoholics. Cutting out alcohol and supplementing thiamine may slow or stop cognitive decline, especially at early stages.

Some experts believe that Wernicke and Korsakoff syndromes are stages of the same disorder, whereas some believe they are separate but closely related.

About 1 or 2% of the worldwide population suffers from Wernicke-Korsakoff syndrome.

If you’re worried about dementia… 

There are more options for dementia than just experimental drugs. Because most dementia treatments have about a 1% chance of success, the need for novel approaches to dementia treatment is critical. Though there are many types of dementia, the most common are often preventable with targeted lifestyle changes.

Want to prevent Alzheimer’s using a plan that works… without breaking the bank? Get our guide to the Bredesen Protocol on a budget for $29.


  1. Bredesen, D. E., Sharlin, K., Jenkins, D., Okuno, M., Youngberg, W., Cohen, S. H., … & Hathaway, A. (2018). Reversal of cognitive decline: 100 patients. J Alzheimers Dis Parkinsonism, 8(450), 2161-0460. Full text: https://www.researchgate.net/profile/Kenneth_Sharlin2/publication/329063941_Reversal_of_Cognitive_Decline_100_Patients/links/5d965c00458515c1d391b494/Reversal-of-Cognitive-Decline-100-Patients.pdf
  2. Krasnianski, A., Bohling, G. T., Harden, M., & Zerr, I. (2015). Psychiatric symptoms in patients with sporadic Creutzfeldt-Jakob disease in Germany. The Journal of clinical psychiatry, 76(9), 1209-1215. Abstract: https://pubmed.ncbi.nlm.nih.gov/25938948/ 
  3. Galvin, J. E. (2015). Improving the clinical detection of Lewy body dementia with the Lewy body composite risk score. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 1(3), 316-324. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4576496/ 
  4. Mez, J., Daneshvar, D. H., Kiernan, P. T., Abdolmohammadi, B., Alvarez, V. E., Huber, B. R., … & Cormier, K. A. (2017). Clinicopathological evaluation of chronic traumatic encephalopathy in players of American football. Jama, 318(4), 360-370. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807097/ 
  5. Schwenkenbecher, P., Pul, R., Wurster, U., Conzen, J., Pars, K., Hartmann, H., … & Skripuletz, T. (2017). Common and uncommon neurological manifestations of neuroborreliosis leading to hospitalization. BMC infectious diseases, 17(1), 90. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5251276/ 
  6. Crutch, S. J., Lehmann, M., Schott, J. M., Rabinovici, G. D., Rossor, M. N., & Fox, N. C. (2012). Posterior cortical atrophy. The Lancet Neurology, 11(2), 170-178. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3740271/ 
  7. Akhouri, S., Kuhn, J., & Newton, E. J. (2017). Wernicke-Korsakoff Syndrome. Full text: https://www.ncbi.nlm.nih.gov/books/NBK430729/
  8. Gustafson, C. (2015). Dale E. Bredesen, MD: Reversing Cognitive Decline. Integrative Medicine: A Clinician’s Journal, 14(5), 26. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712873/
PrimeHealth Newsletter
Get tips & advice right to your inbox, plus stay up to date on PrimeHealth group visits and services.

Share this Post